Plasma homocysteine and insulin in diabetic nephropathy: Relationship to body mass index

Renal Failure

Volumn 26, Issue 6, 2004, Pages 689-693

  Sandhu, J S ^a   Singh, Inderpal ^a   Aggarwal, S P ^a   Narang, A P S ^a   Sandhu, P ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Diabetic nephropathy; Homocysteine; Insulin; Type 2 diabetes mellitus

Indexed keywords

HOMOCYSTEINE; INSULIN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INDIA; INSULIN BLOOD LEVEL; KIDNEY FAILURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 9644304545     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200037138     Document Type: Article

References (25)

1. Ueland, P.M.; Refsum, H.; Stabler, S.P.; Malinow, M.R.; Anderson, A.; Allen, R.H. Total homocysteine in plasma or serum methods and clinical applications. Clin. Chem. 1993, 39, 1764-1779.
2. Boushey, B.S.; Beresford, S.A.; Omen, G.S.; Motulsky, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular diseases: probable benefits of increasing folic acid intakes. JAMA 1995, 274, 1049-1057.
3. 12 and folate. Am. J. Epidemiol. 1996, 143, 845-859.
4. Chico, A.; Perez, A.; Cordoba, A.; Arcelus, R.; Carreras, G.; de Leiva, A.; Gonzalez-Sastre, F.; Blanco-Vaca, F. Plasma homocysteine is related to albumin excretion rate in-patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998, 41, 684-693.
5. Fiorina, P.; Lanfredini, M.; Montanari, A.; Peca, M.G.; Veronelli, A.; Mello, A.; Astorri, E.; Craveri, A. Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus. Am. J. Hypertens. 1998, 11, 1100-1107.
6. Hoogeveen, E.K.; Kostense, P.J.; Jager, A.; Heine, R.J.; Jakobs, C.; Bouter, L.M.; Donker, A.J.; Stehouwer, C.D. Serum homocysteine levels and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int. 1998, 54, 203-209.
7. Munshi, M.N.; Stone, A.; Fink, L.; Fonseca, V. Hyperhomocysteinemia following a methionine load in patients with noninsulin dependent diabetes mellitus and macro vascular disease. Metabolism 1996, 45, 133-135.
8. Okada, E.; Oida, K.; Tada, H.; Aszuma, K.; Eguchi, K.; Tohda, G.; Kosaka, S.; Takahashi, S.; Miyamori, I. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2000, 22, 484-490.
9. Reaven, G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1998, 37, 1595-1607.
10. Jacobs, R.L.; House, J.D.; Brosnan, M.E.; Brosnan, J.T. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 1998, 47, 1967-1970.
11. Das, S.; Reynolds, T.; Patnaik, A.; Rais, N.; Fink, L.M.; Fonxeca, V.A. Plasma homocysteine concentrations in type 2 diabetic patients in India. J. Diabetes Its Complicat. 1999, 13, 200-203.
12. Gallistl, S.; Erwa, W.; Sudi, K.; Borkenstein, M.; Mangge, H. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 2000, 23, 1348-1351.
13. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus; World Health Organization: Geneva, 1999.
14. Hofmann, M.A.; Kohl, B.; Zumbach, M.S.; Borcea, V.; Bierhaus, A.; Henkels, M.; Amiral, J.; Fiehn, W.; Zieglr, R.; Wahl, P.; Nawroth, P.P. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care 1997, 20, 1880-1886.
15. Hultberg, B.; Agardh, E.; Andersson, A.; Brattstrom, L.; Isakasson, A.; Isreaelsson, B.; Agardh, C.D. Increased levels of plasma associated with nephropathy, but not sever retinopathy in type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 1991, 51, 277-282.
16. Freidman, A.N.; Bostom, A.G.; Selhub, J.; Levey, A.S.; Rosenberg, I.H. The kidney and homocysteine metabolism. J. Am. Soc. Nephrol. 2001, 12, 2181-2189.
17. Hoogeveen, E.K.; Kostense, P.J.; Berks, P.J.; Makaay, A.J.; Jakobs, C.; Bouter, L.M.; Heine, R.J.; Stehouwer, C.D.A. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin depend diabetes mellitus: a population based study. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 133-138.
18. Giles, W.H.; Croft, J.B.; Greenlund, K.J.; Ford, E.S.; Kittner, S.J. Total homocysteine concentration and the likelihood of nonfatal stroke. Results from the third National Health and Nutrition Examination Survey, 1988, 1994. Stroke 1998, 29, 2473-2477.
19. Araki, A.; Sako, Y.; Ito, H. Plasma homocysteine concentrations in Japanese patients with non-insulin dependent diabetes mellitus: effect of parental methylcobalamin treatment. Atherosclerosis 1993, 103, 149-157.
20. Giltay, E.J.; Hoogeveen, E.K.; Elbers, J.H.M.; Gooren, L.J.G.; Asscheman, H.; Stehouwer, C.D.A. Insulin resistance is associated with elevated plasma total homocysteine levels in health, non obese subject. Atherosclerosis 1998, 139, 197-198.
21. Abbasi, F.; Facchini, F.; Humphreys, M.H.; Reaven, G.M. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999, 146, 175-178.
22. Bar-on, H.; Kidron, M.; Friedlander, Y.; Ben-Yehuda, A.; Selhub, J.; Rosenberg, I.H.; Friedman, G. Plasma total homocysteine levels in subjects with hyperinsulinemia. J. Intern. Med. 2000, 247, 287-294.
23. Soino, M.; Marniemi, J.; Laakso, M.; Lehto, S.; Rönnema, T. Elevated plasma homocysteine levels is an independent predictor of coronary artery disease events in type 2 diabetes mellitus. Ann. Int. Med. 2004, 140 (2), 94-100.
24. Bostom, A.G.; Lathrop, L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997, 52, 10-20.
25. Woo, K.S.; Chook, P.; Lolin, Y.I.; Cheung, A.S.; Chan, L.T.; Sunn, Y.Y.; et al. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997, 96, 2542-2544.